Latest filing published 26 May 2023 for 達亞, €18.5M.
Insider track record
No signal scores available.
益安生醫股份有限公司: trading record in brief
益安生醫股份有限公司 is a declared insider of 達亞, with filings sourced from TWSE / TPEx (MOPS). In total, 8 filings cover trades dated from 12 December 2019 to 26 May 2023.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 26 May 2023 with a transaction in 達亞. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.
Companies and markets linked to 益安生醫股份有限公司
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,591,000 sharesShareTPExTWMOPS:6762:112/05/26:益安生醫股份有限公司:062lr6t
- 3,600,000 sharesShareTPExTWMOPS:6762:112/05/09:益安生醫股份有限公司:0g8r8i7
- 3,600,000 sharesShareTPExTWMOPS:6762:112/05/04:益安生醫股份有限公司:1ktsg22
- 1,300,000 sharesShareTPExTWMOPS:6762:110/07/16:益安生醫股份有限公司:1opjg0a
- 3,600,000 sharesShareTPExTWMOPS:6762:110/06/25:益安生醫股份有限公司:0gvx8lx
- 311,000 sharesShareTPExTWMOPS:6762:110/03/12:益安生醫股份有限公司:0bj1zf7
- 311,000 sharesShareTPExTWMOPS:6762:109/12/08:益安生醫股份有限公司:0rdgyg0
- 387,000 sharesShareTPExTWMOPS:6762:108/12/12:益安生醫股份有限公司:0t810da
8 of 8 declarations